vidarabine has been researched along with Cardiac Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Hayakawa, Y; Ishikawa, M; Ito, A; Kawahara, H; Kiyomoto, K; Matsuo, I; Morii, A; Mototani, Y; Nariyama, M; Ohnuki, Y; Okumura, S; Suita, K; Tsunoda, M | 1 |
Bolster, L; Brandwein, J; Ghosh, S; Hamilton, M; Larratt, L; Liew, E; Mant, M; Patterson, JM; Peters, A; Ritchie, B; Saini, L; Sandhu, I; Turner, R; Wu, C; Zhu, N | 1 |
Abidi, MH; Braun, TM; Ibrahim, RB; Khaled, YA; Krijanovski, OI; Levine, JE; Mineishi, S; Peres, E | 1 |
Imamura, T; Kadota, J; Kikuchi, H; Kohno, K; Ogata, M; Ohtsuka, E; Tomo, T | 1 |
4 other study(ies) available for vidarabine and Cardiac Diseases
Article | Year |
---|---|
Vidarabine, an anti-herpes agent, prevents occlusal-disharmony-induced cardiac dysfunction in mice.
Topics: Adenylyl Cyclases; Animals; Apoptosis; Heart; Heart Diseases; Mice; Mice, Knockout; Myocytes, Cardiac; Vidarabine | 2022 |
The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac disease.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Comorbidity; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Heart Diseases; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Retrospective Studies; Treatment Outcome; Vidarabine; Young Adult | 2016 |
Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation.
Topics: Adult; Aged; Anthracyclines; Arrhythmias, Cardiac; Busulfan; Female; Heart Diseases; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation | 2010 |
Successful reduced intensity allogeneic stem cell transplantation for systemic AL amyloidosis.
Topics: Adult; Amyloidosis; Diarrhea; Drug Therapy, Combination; Heart Diseases; Humans; Hypotension; Japan; Kidney Diseases; Male; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2006 |